41
NPS Score
VS
Allergan
- EMPLOYEE
PARTICIPANTS - 76
- TOTAL
RATINGS
Revance Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 21
- TOTAL
RATINGS
Allergan vs Revance Therapeutics
Compare Allergan versus Revance Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 76 employees and customers of Allergan and 21 employees and customers of Revance Therapeutics.
Allergan
Allergan's brand is ranked #675 in the list of Global Top 1000 Brands, as rated by customers of Allergan. Their current market cap is $63.36B.
Revance Therapeutics
Revance Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Revance Therapeutics. Their current market cap is $2.39B.
4/5
Product Quality
4.2/5
4/5
Pricing
4.2/5
4/5
Customer Service
4.1/5
| 65% | Promoters |
|---|---|
| 11% | Passive |
| 24% | Detractors |
65
NPS Score
| 79% | Promoters |
|---|---|
| 7% | Passive |
| 14% | Detractors |
Net Promoter Score
Winner by 24
See how Allergan compares to its competitors
Working at Allergan vs Working at Revance Therapeutics
72 / 100
CEO Rating
Winner by 13%
59 / 100
CEO Rating
Allergan
Allergan doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Revance Therapeutics
Employees at Revance Therapeutics rate their CEO, Mark Foley, 59/100. This score is 13% lower than the scores of Allergan's CEO, Brenton Saunders.